BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 15698632)

  • 1. Protective effect of dexamethasone on osmotic-induced demyelination in rats.
    Sugimura Y; Murase T; Takefuji S; Hayasaka S; Takagishi Y; Oiso Y; Murata Y
    Exp Neurol; 2005 Mar; 192(1):178-83. PubMed ID: 15698632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms and therapy of osmotic demyelination.
    Murase T; Sugimura Y; Takefuji S; Oiso Y; Murata Y
    Am J Med; 2006 Jul; 119(7 Suppl 1):S69-73. PubMed ID: 16843088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of microglia in the pathogenesis of osmotic-induced demyelination.
    Takefuji S; Murase T; Sugimura Y; Takagishi Y; Hayasaka S; Oiso Y; Murata Y
    Exp Neurol; 2007 Mar; 204(1):88-94. PubMed ID: 17126835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood-brain barrier disruption and complement activation in the brain following rapid correction of chronic hyponatremia.
    Baker EA; Tian Y; Adler S; Verbalis JG
    Exp Neurol; 2000 Oct; 165(2):221-30. PubMed ID: 10993682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevention of central pontine myelinolysis in rats by early treatment with dexamethasone].
    Ke QH; Chen JH; Zheng SS; Yu J; Liang TB
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2006 Jul; 35(4):424-9. PubMed ID: 16924708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in cerebral blood flow and distribution associated with acute increases in plasma sodium and osmolality of chronic hyponatremic rats.
    Adler S; Verbalis JG; Meyers S; Simplaceanu E; Williams DS
    Exp Neurol; 2000 May; 163(1):63-71. PubMed ID: 10785445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic recommendations for management of severe hyponatremia: current concepts on pathogenesis and prevention of neurologic complications.
    Soupart A; Decaux G
    Clin Nephrol; 1996 Sep; 46(3):149-69. PubMed ID: 8879850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central pontine myelinolysis: historical and mechanistic considerations.
    Norenberg MD
    Metab Brain Dis; 2010 Mar; 25(1):97-106. PubMed ID: 20182780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study of the pathogenesis and prevention of central pontine myelinolysis in a rat model.
    Ke QH; Liang TB; Yu J; Zheng SS
    J Int Med Res; 2006; 34(3):264-71. PubMed ID: 16866020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re-induction of hyponatremia after rapid overcorrection of hyponatremia reduces mortality in rats.
    Gankam Kengne F; Soupart A; Pochet R; Brion JP; Decaux G
    Kidney Int; 2009 Sep; 76(6):614-21. PubMed ID: 19606078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minocycline prevents osmotic demyelination associated with aquaresis.
    Takagi H; Sugimura Y; Suzuki H; Iwama S; Izumida H; Fujisawa H; Ogawa K; Nakashima K; Ochiai H; Takeuchi S; Kiyota A; Suga H; Goto M; Banno R; Arima H; Oiso Y
    Kidney Int; 2014 Nov; 86(5):954-64. PubMed ID: 24759153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of duration of osmotherapy on blood-brain barrier disruption and regional cerebral edema after experimental stroke.
    Chen CH; Toung TJ; Sapirstein A; Bhardwaj A
    J Cereb Blood Flow Metab; 2006 Jul; 26(7):951-8. PubMed ID: 16306935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positive association between blood brain barrier disruption and osmotically-induced demyelination.
    Adler S; Martinez J; Williams DS; Verbalis JG
    Mult Scler; 2000 Feb; 6(1):24-31. PubMed ID: 10694842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extrapontine myelinolysis in infancy: report of a case.
    Haspolat S; Duman O; Senol U; Yegin O
    J Child Neurol; 2004 Nov; 19(11):913-5. PubMed ID: 15658799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of central pontine myelinolysis and extrapontine myelinolysis during rapid correction of hypernatremia].
    Go M; Amino A; Shindo K; Tsunoda S; Shiozawa Z
    Rinsho Shinkeigaku; 1994 Nov; 34(11):1130-5. PubMed ID: 7729094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current perspectives in the management of hyponatremia: prevention of CPM.
    Sterns RH; Silver S; Kleinschmidt-DeMasters BK; Rojiani AM
    Expert Rev Neurother; 2007 Dec; 7(12):1791-7. PubMed ID: 18052771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High incidence of neurologic complications following rapid correction of severe hyponatremia in polydipsic patients.
    Tanneau RS; Henry A; Rouhart F; Bourbigot B; Garo B; Mocquard Y; Goas JY
    J Clin Psychiatry; 1994 Aug; 55(8):349-54. PubMed ID: 8071304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronicity of hyponatremia as a factor in experimental myelinolysis.
    Norenberg MD; Papendick RE
    Ann Neurol; 1984 Jun; 15(6):544-7. PubMed ID: 6742788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myoinositol administration improves survival and reduces myelinolysis after rapid correction of chronic hyponatremia in rats.
    Silver SM; Schroeder BM; Sterns RH; Rojiani AM
    J Neuropathol Exp Neurol; 2006 Jan; 65(1):37-44. PubMed ID: 16410747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid correction of hyponatremia causes demyelination: relation to central pontine myelinolysis.
    Kleinschmidt-DeMasters BK; Norenberg MD
    Science; 1981 Mar; 211(4486):1068-70. PubMed ID: 7466381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.